Main findings
This randomized, single-center, open-label trial was launched to explore whether full ERAS perioperative management would improve surgical outcomes in patients undergoing simple gynaecologic laparoscopic procedures compared with a limited ERAS program. Our study showed that the full ERAS pathway further improved patient outcome by shortening the length of stay, reducing postoperative pain, reducing narcotics consumption, and improving the quality of life—while not compromising morbidity or the readmission rate within 30 days after surgery.